{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-23-002224","form_type":"8-K/A","ticker":"TLRY","cik":"0001731348","company_name":"Tilray Brands, Inc.","filed_at":"2023-04-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.280831+00:00","generated_at":"2026-06-17T03:41:51.771659+00:00","sec_items":["2.02","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Tilray Q3 revenue $145.6M, adjusted EBITDA $14M; acquires HEXO for ~$56M","bullets":["Net revenue $145.6M, up from $144.1M prior quarter; constant-currency revenue $154.2M (+2% YoY).","Adjusted EBITDA $14.0M, 16th consecutive positive quarter; reiterated FY23 adjusted EBITDA guidance of $60-66M.","Acquires 100% of HEXO Corp. for ~$56M in stock (0.4352 Tilray shares per HEXO share); expected close June 2023.","Pro-forma Canadian cannabis market share of 12.9% and #1 position; net sales ~$215M from combined Canadian operations.","Cash and marketable securities $408.3M; reiterated positive free cash flow from operating segments in FY23."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-23-002224","json":"https://secwatch.observer/filing/0001171843-23-002224.json","markdown":"https://secwatch.observer/filing/0001171843-23-002224.md","text":"https://secwatch.observer/filing/0001171843-23-002224.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1731348/000117184323002224/0001171843-23-002224-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1731348/000117184323002224/f8ka_041023.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T03:41:51.771659+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5bdb11aeb2a46792961dd782220fe5227570ed2f","claim":"Tilray Brands, Inc. reported third fiscal quarter ended February 28, 2023 results: revenue $145.6 million. Guidance reaffirmed.","evidence_excerpt":"Delivered $145.6 Million in Net Revenue and 16 th Consecutive Quarter of Positive Adjusted EBITDA Maintained #1 Cannabis Market Share Position in Canada, the Largest Federally Legal","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1731348/000117184323002224/0001171843-23-002224-index.htm","confidence":0.85,"family_label":"Earnings Releases","details":[{"label":"Period","value":"third fiscal quarter ended February 28, 2023"},{"label":"Revenue","value":"$145.6 million"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}